• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
EYEN

EYEN

Eyenovia, Inc.

NASDAQHealthcareBiotechnologyUS

USD7.56

+0.29 (+3.99%)

Company Profile

CEO

Michael M. Rowe

IPO Date

2018-01-25

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$7.54

Prev. Close

$7.27

Day Low

$7.28

Day High

$7.82

52W Low

$0.85

52W High

$124.80

Market Cap

$0.04B

Volume

0.03M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

51.8%

Avg Negative

2.5%

Avg Neutral

45.6%

News Feed

Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation

Seeking Alpha·6/2/2021·↑ positive

Eyenovia Stock Shoots Higher on Positive MicroLine Data in Late-Stage Presbyopia Study

Benzinga·5/25/2021·↑ positive

Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of MicroLine for the Treatment of Presbyopia

GlobeNewsWire·
5/25/2021
·↑ positive

Eyenovia: Still A Great Long-Term Investment In Ophthalmology

Seeking Alpha·5/21/2021·↑ positive

Eyenovia's (EYEN) CEO Sean Ianchulev on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/12/2021·↓ negative

Eyenovia Announces New $25 Million Credit Facility with Silicon Valley Bank

GlobeNewsWire·5/10/2021·↑ positive

Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/25/2021·↓ negative

Eyenovia Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewsWire·3/25/2021·↓ negative

Eyenovia and EVERSANA Announce Partnership to Support the Potential Launch and Commercialization of MydCombi™ for Mydriasis

Business Wire·3/23/2021·↑ positive

Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of its MAP™ Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasis

Business Wire·3/17/2021·↑ positive